Advancements in Small-cell Lung Cancer: The Changing Landscape Following IMpower-133-Reference-Cited by-同舟云学术

Advancements in Small-cell Lung Cancer: The Changing Landscape Following IMpower-133

Published:2019-05 Issue:3 Volume:20 Page:148-160.e2
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Pacheco Jose,Bunn Paul A.

Funder

Pfizer

AstraZeneca

University of Colorado Lung Cancer SPORE

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference74 articles.

1. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer;Horn;N Engl J Med,2018

2. Impact of tumor mutation burden on the efficacy of nivolumab or nivolumab + ipilimumab in small cell lung cancer: an exploratory analysis of CheckMate 032;Antonia,2017

3. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial;Antonia;Lancet Oncol,2016

4. Tumor mutational burden and efficacy of nivolumab monotherapy and in combination with ipilimumab in small-cell lung cancer;Hellmann;Cancer Cell,2018

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extensive Stage Small-Cell Lung Cancer with Cystic Brain Metastases: A Report of Two Cases;Cancer Management and Research;2024-03

2. Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab;Oncology and Therapy;2024-01-27

3. A study on expression of programmed death ligand-1 in small cell lung carcinoma and correlation with clinicopathological parameters;Polish Journal of Pathology;2024

4. A nomogram for predicting severe myelosuppression in small cell lung cancer patients following the first-line chemotherapy;Scientific Reports;2023-10-14

5. Investigation of the efficacy and feasibility of combined therapy of PD‐L1‐enhanced exogenous peripatetic adoptive natural killer (NK) cells in combination with antiangiogenic targeted therapy in the treatment of extensive‐stage small cell lung cancer;Thoracic Cancer;2023-08-19